Fluder-Wlodarczyk, J.; Pawłowski, S.; Chuchra, P.J.; Pawłowski, T.; Wojakowski, W.; Gasior, P.
Importance of Short-Term Neointimal Coverage of Drug-Eluting Stents in the Duration of Dual Antiplatelet Therapy. J. Clin. Med. 2024, 13, 1730.
https://doi.org/10.3390/jcm13061730
AMA Style
Fluder-Wlodarczyk J, Pawłowski S, Chuchra PJ, Pawłowski T, Wojakowski W, Gasior P.
Importance of Short-Term Neointimal Coverage of Drug-Eluting Stents in the Duration of Dual Antiplatelet Therapy. Journal of Clinical Medicine. 2024; 13(6):1730.
https://doi.org/10.3390/jcm13061730
Chicago/Turabian Style
Fluder-Wlodarczyk, Joanna, Sławomir Pawłowski, Piotr J. Chuchra, Tomasz Pawłowski, Wojciech Wojakowski, and Pawel Gasior.
2024. "Importance of Short-Term Neointimal Coverage of Drug-Eluting Stents in the Duration of Dual Antiplatelet Therapy" Journal of Clinical Medicine 13, no. 6: 1730.
https://doi.org/10.3390/jcm13061730
APA Style
Fluder-Wlodarczyk, J., Pawłowski, S., Chuchra, P. J., Pawłowski, T., Wojakowski, W., & Gasior, P.
(2024). Importance of Short-Term Neointimal Coverage of Drug-Eluting Stents in the Duration of Dual Antiplatelet Therapy. Journal of Clinical Medicine, 13(6), 1730.
https://doi.org/10.3390/jcm13061730
